RevBio is focused on developing innovative bone repair technology through its flagship product, Tetranite, which is an injectable, self-setting, osteoconductive bone adhesive biomaterial. This synthetic adhesive is designed to bond bone to bone and bone to metal in wet environments and is currently under FDA review for various applications in oral, craniofacial, orthopedic, and neurosurgical fields. Tetranite biodegrades over time, being replaced by new bone as part of the natural bone remodeling process, and serves as a scaffold to facilitate bone growth. By reducing the duration and complexity of medical procedures, RevBio's technology enables more minimally invasive surgeries and aims to improve patient outcomes by decreasing recovery time, pain, and overall costs associated with care. The company is building a diverse portfolio of applications within both dental and orthopedic markets.
Perceptive is focused on the design, development, and manufacturing of medical devices specifically for the dentistry sector. The company has pioneered automated robotics technology that aims to revolutionize dental care by establishing image-guided robotic restorative dentistry as a standard practice. This innovative technology enhances the precision with which dentists can identify and eliminate tooth decay, ultimately delivering superior restorations to patients more efficiently and at a reduced cost. By leveraging advanced techniques, Perceptive enhances clinical capacity and aims to improve overall dental care practices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.